Showing results (241-250 of 5,582) with videos related to

Sort By:
Pageof 559
Nuclear Medicine Communications|December 1, 1996
Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPETG Schulz, J von Dahl, H J Kaiser, et al.
Nuclear Medicine Communications|March 1, 1997
Transmission scanning for attenuation correction of myocardial 201Tl images in obese patientsE M Prvulovich, A H Lonn, J B Bomanji, et al.
Nuclear Medicine Communications|March 1, 1997
Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarateA D Petrov, J Narula, A Nakazawa, et al.
Nuclear Medicine Communications|March 1, 1997
Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestationsP Colamussi, F Trotta, R Ricci, et al.
Nuclear Medicine Communications|August 1, 1996
Complications and difficulties in radiolabelling blood cells: a reviewC B Sampson
Nuclear Medicine Communications|August 1, 1996
Stress-reinjection 201Tl scintigraphy without redistribution imaging: prediction of the effect of coronary artery bypass grafting on regional myocardial 201Tl uptakeA F Kuijper, B L van Eck-Smit, M G Niemeyer, et al.
Nuclear Medicine Communications|August 1, 1996
Fatty acid metabolic imaging with 123I-BMIPP for the diagnosis of coronary artery disease: application to patients with diabetes mellitus and hyperlipidaemiaY Takeishi, H Atsumi, S Fujiwara, et al.
Nuclear Medicine Communications|August 1, 1996
Assessment of completeness of thyroid ablation by estimation of neck uptake of 131I on whole-body scans: comparison of quantification and visual assessment of thyroid bed uptakeS Chopra, M L Wastie, S Chan, et al.
Nuclear Medicine Communications|August 1, 1996
Evaluation of external radiation exposure rate from radioiodine-treated hyperthyroid patients and radiation safety considerationsM Demir, L Kabasakal, C Onsel
Nuclear Medicine Communications|August 1, 1996
Reduction of 123I-iomazenil uptake in haemodynamically and metabolically impaired brain areas in patients with cerebrovascular diseaseK Hayashida, Y Hirose, Y Tanaka, et al.
Pageof 559